PDSB - PDS Biotech

-

$undefined

N/A

(N/A)

PDS Biotech NASDAQ:PDSB PDS Biotech is a clinical-stage immunotherapy company with a growing pipeline of cancer immunotherapies and infectious disease vaccines based on the Company's proprietary Versamune® T-cell activating technology platform. Versamune® effectively delivers disease-specific antigens for in vivo uptake and processing, while also activating the critical type 1 interferon immunological pathway, resulting in production of potent disease-specific killer T-cells as well as neutralizing antibodies. PDS Biotech has engineered multiple therapies, based on combinations of Versamune® and disease-specific antigens, designed to train the immune system to better recognize disease cells and effectively attack and destroy them.

Location: 25B Vreeland Road, Suite 300, New Jersey, 07932, United States | Website: www.pdsbiotech.com | Industry: Pharmaceutical Preparation Manufacturing | Sector: Manufacturing


Market Cap

NaN

52 Wk Range

$ - $

Previous Close

$N/A

Open

$N/A

Day Range

N/A - N/A

Volume

N/A

Avg Volume

N/A

Enterprise Value

40.65M

Cash

57.73M

Avg Qtr Burn

-8.607M

Short % of Float

12.62%

Insider Ownership

3.99%

Institutional Own.

12.36%

Qtr Updated

06/30/24


Drug Pipeline

Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.

Drug & IndicationStage & EventCatalyst Date
Versamune® HPV (PDS0101) + Keytruda Details
Head and neck squamous cell carcinoma, Cancer

Phase 3

Initiation

Phase 2

Data readout

Versamune® HPV + PDS01ADC + pembrolizumab Details
Head and neck squamous cell carcinoma, Cancer

Phase 2

Data readout

Versamune® HPV (PDS0101) + Keytruda Details
Cancer, Solid tumor/s, HPV+ oropharyngeal cancer

Phase 2

Data readout

PDS01ADC + ICI Details
Human papillomavirus

Phase 2

Data readout

Phase 2

Update

PDS0301 + Docetaxel Details
Cancer, Prostate cancer

Phase 1/2

Data readout

PDS01ADC Details
Kaposi Sarcoma

Phase 1/2

Data readout

Phase 1/2

Data readout

Phase 1/2

Data readout